EESystem Triumphs Again: Courts Deem Jason Shurka’s Claims “Baseless” and “Futile” 
Autumn Lighting Fair, Outdoor and Tech Light Expo, Eco Expo Asia draw some 62,000 buyers 
Saudi Arabia Assumes Chairmanship of INTOSAI 
IPO Watch – High-Margin International Business Scales Up Rapidly: Unpacking Hithium Energy Storage’s Global Expansion Ambition Behind its Push for a Hong Kong Listing 
CIMC Group Announces the First Three Quarter Results for 2025 ALX Oncology Reports Second Quarter 2021 Financial Results and Provides Clinical Development and Operational Highlights
BURLINGAME, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq:…
ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2021
Bottom Line: Q2 2021 Net Income of $141,000 versus Q2 2020 Net Loss of ($766,000) PORTLAND,…
Lyell Immunopharma Reports Second Quarter 2021 Financial Results and Business Highlights
Achieved operational readiness of state-of-the-art LyFE manufacturing facility to support multiple clinical trials Cash, cash…
Kronos Bio Reports Recent Business Progress and Second Quarter Financial Results
Announced FDA clearance of Investigational New Drug application (IND) for lanraplenib (LANRA) for treatment of…
Vincerx Pharma Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
First patient dosed in Phase 1b study of VIP152 in MYC-driven relapsed or refractory aggressive…
Angion Provides Corporate Update and Reports Second Quarter 2021 Financial Results
— Topline data in ANG-3777 Phase 3 study now expected to be announced in early…
Motus GI Reports Second Quarter 2021 Financial Results and Provides Corporate Update
Reported a 95% revenue increase versus Q1 2021; the fourth consecutive quarter of revenue growth…
89bio Reports Second Quarter 2021 Financial Results and Provides Corporate Update
– Initiated Phase 2b ENLIVEN trial in NASH patients –– Completed enrollment in NASH histology…
Homology Medicines Reports Second Quarter 2021 Financial Results and Recent Highlights
– On Track to Report Initial Results from Phase 2 pheNIX Gene Therapy Trial for…
Atea Pharmaceuticals Provides Clinical and Corporate Update and Reports Second Quarter 2021 Financial Results
New Data in Healthy Volunteers Confirmed that AT-527’s Active Metabolite Achieved Target Antiviral Levels in…
Bellicum Reports Second Quarter 2021 Financial Results and Provides Operational Update
– Entered into a licensing agreement with two leading oncology research and treatment centers for…
Relay Therapeutics Announces Corporate Updates and Reports Second Quarter 2021 Financial Results
Company selected RLY-2608 as PI3Kα mutant inhibitor development candidate and plans to initiate first-in-human study…
Chinook Therapeutics Provides Business Update and Reports Second Quarter 2021 Financial Results
SEATTLE, Aug. 12, 2021 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company…
Bolt Biotherapeutics Reports Second Quarter 2021 Financial Results and Provides Business Highlights
– BDC-1001 Phase 1/2 trial in HER2-expressing solid tumors on track for data update in…
4D Molecular Therapeutics Reports Financial Results for the Second Quarter of 2021 and Provides Operational Highlights
EMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) — 4D Molecular Therapeutics (Nasdaq: FDMT), a clinical-stage…
Nkarta Reports Second Quarter 2021 Financial Results and Business Progress
Initial data from NKX101 clinical trial expected by end of 2021 NKX019 patient dosing expected…
Adicet Reports Second Quarter 2021 Financial Results and Provides Business Updates
On track to report top-line interim data from ADI-001 Phase 1 study in Non-Hodgkin’s Lymphoma…
Eledon Pharmaceuticals Reports Second Quarter 2021 Operating and Financial Results
Received approval from Health Canada to initiate a clinical trial of AT-1501 in kidney transplantation;…
CorMedix Inc. Reports Second Quarter and Six Month 2021 Financial Results and Provides Business Update
Conference Call Scheduled for Today at 4:30 p.m. Eastern Time BERKELEY HEIGHTS, N.J., Aug. 12,…
Myovant Sciences Appoints Uneek Mehra as Chief Financial and Business Officer
BASEL, Switzerland, Aug. 12, 2021 (GLOBE NEWSWIRE) — Myovant Sciences (NYSE: MYOV), a healthcare company…